Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03098329 · ClinicalTrials.gov registry record · NA
Check it: A New Approach to Controlling Chlamydia Transmission in Young People
A NA study, sponsored by Tulane University.
- Completed
- Registry status
- NA
- Development phase
- 1,907
- Enrollment target
NCT03098329 is a NA study that has completed, run by Tulane University. The registered enrollment target is 1,907 participants.
The verdict
NCT03098329, a NA study, has completed, sponsored by Tulane University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,907 participants
- Enrollment target
Study Summary
This study, named "Check it," is a bundled program for African American (AA) men ages 15-24 that includes community testing for chlamydia and gonorrhea, expedited treatment for subjects who test positive and their female sexual contacts, and rescreening for these two sexually transmitted infections.
Interventions
- OTHER Ct/GC screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,907 participants |
| Start Date | 2017-05-22 |
| Est. Completion | 2021-05-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03098329
The ClinicalTrials.gov registry entry for NCT03098329 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,907 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ct/GC screening is the first listed.
NCT03098329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03098329 about?
NCT03098329 is a clinical study titled "Check it: A New Approach to Controlling Chlamydia Transmission in Young People". This study, named "Check it," is a bundled program for African American (AA) men ages 15-24 that includes community testing for chlamydia and gonorrhea, expedited treatment for subjects who test positive and their female sexual contacts, and rescreening for these two sexually transmitted infections.
What is the current status of trial NCT03098329?
This trial is currently completed. It is a NA study. The enrollment target is 1,907 participants. The study started on 2017-05-22. Estimated completion is 2021-05-28.
What interventions are being tested in trial NCT03098329?
The interventions under investigation include: Ct/GC screening (OTHER).
Who is sponsoring clinical trial NCT03098329?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.